Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Reva Medical Inc.
DescriptionBioresorbable sirolimus-eluting coronary stent
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentPilot
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today